News Archive

/static/apps/cms/news/1639/Natalie Farwell 500.jpg

Enhancing Heart Failure Patient Care with the MOS Dashboard

June 3, 2025 / Dqhi

Heart failure with reduced ejection fraction (HFrEF), which measures your heart’s ability to pump oxygen-rich blood out to your body, remains a leading cause of death and hospitalization worldwide. Over the last three decades, clinical trials have highlighted the efficacy of four key medication classes- Beta-blockers, angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor-neprilysin inhibitors (ARNI), and sodium-glucose cotransporter 2 inhibitors (SGLT2i). Together, these medications form the pillars of guideline-directed medical therapy (GDMT), which has significantly improved patient outcomes, contributing to up to a 70% reduction in mortality among HFrEF patients.

FULL STORY
/static/apps/cms/news/1524/EP01-S2-Cover-SM.jpg

Dr. David Gordon: What is Cardiovascular Pathology?

February 26, 2024 / Path Report

  S2, EP1

In this episode, Dr. David Gordon, a cardiovascular pathologist, stops by The Path Report to discuss his specialty, hereditary heart conditions, and more.

 

FULL STORY